BIOCARDIA, INC. [●] Shares of Common Stock Underwriting AgreementBioCardia, Inc. • July 6th, 2015 • Biological products, (no disgnostic substances) • New York
BioCardia, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), an aggregate of 3,846,154 shares of common stock, par value $0.001 per share (“Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 576,923 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”
BIOCARDIA, INC. FORM OF INDEMNIFICATION AGREEMENTIndemnification Agreement • July 6th, 2015 • BioCardia, Inc. • Biological products, (no disgnostic substances) • Delaware
This Indemnification Agreement (this “Agreement”) is dated as of (the “Effective Date”), and is between BioCardia, Inc., a Delaware corporation (the “Company”), and (“Indemnitee”).
